NCT00791921 - Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) | Biotech Hunter

Enrollment

230

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Rheumatoid Arthritis

Interventions

DRUG

CDP870

400mg CDP870 given at Week0, 2, 4 and thereafter 200mg CDP870 given every 2weeks until Week22 subcutaneously(SC)

DRUG

Placebo of CDP870

Placebo given every 2 weeks until Week22 (SC)

Trial Locations (7)

Chube Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushuh Region

Shikoku Region